Orca Pharmaceuticals Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.61M
Latest Deal Amount
  • Investors
  • 2

Orca Pharmaceuticals General Information

Description

Developer of drugs designed to provide treatment of autoimmune diseases. The company's drugs help to correct the imbalance in pathogenic T cells and regulatory T cells in autoimmune diseases such as psoriasis, ankylosing spondylitis and inflammatory bowel disease, enabling patients to get treated more efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • The Innovation Centre
  • 99 Park Drive, Milton Park
  • Abingdon OX14 4RY
  • England, United Kingdom
+44 01235 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orca Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 14-Aug-2014 $2.61M 00.000 Completed Generating Revenue
To view Orca Pharmaceuticals’s complete valuation and funding history, request access »

Orca Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Dan Littman Co-Founder & Advisor
Jun Huh Co-Founder & Advisor
Michael Hunter Ph.D Co-Founder & Advisor
Roy Pettipher Ph.D Co-Founder & Advisor
Mark Payton Ph.D Co-Founder& Senior Consultant
To view Orca Pharmaceuticals’s complete executive team members history, request access »

Orca Pharmaceuticals Board Members (4)

Name Representing Role Since
Baiju Shah JD BioMotiv Board Member 000 0000
David U'Prichard Ph.D BioMotiv Chairman 000 0000
Theodore Torphy Ph.D BioMotiv Board Member & Advisor 000 0000
Thomas Facklam Ph.D BioMotiv Board Member 000 0000
To view Orca Pharmaceuticals’s complete board members history, request access »

Orca Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioMotiv VC-Backed Company Minority 000 0000 000000 0
NYU Innovation Venture Fund Accelerator/Incubator Minority 000 0000 000000 0
To view Orca Pharmaceuticals’s complete investors history, request access »